www.fdanews.com/articles/113709-genzyme-biosurgery-shareholders-receive-64-million-settlement

Genzyme Biosurgery Shareholders Receive $64 Million Settlement

January 13, 2009

Shareholders of Genzyme Biosurgery, the former tracking stock of the Genzyme Corporation, received their $64 million settlement from the Class Action lawsuit filed against Genzyme Corporation. …
Yahoo! Finance